NOVARTIS
NOVARTIS is named as the registrant in 1 lobbying report we hold for 2026-Q2, for 1 client. 0 reports of 1 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| NOVARTISThe registrant lobbying for itself | 2026-Q2: $1,410,000 in its own lobbying expenses | 1 |
Lobbyists named in these reports
- COURTNEY LEE-ASHLEY · 1 report
- COURTNEY PIRON · 1 report
- JOSEPH MCGOWAN · 1 report
- NANCY TRAVIS · 1 report
- PETER STEHOUWER · 1 report
- SARAH DURR · 1 report
- TAYLOR BOOTH · 1 report
- THOMAS ANDREW SUTER · 1 report
Bills named, and how the House and the Senate voted
35 bills named in these reports. 3 of them became law, and our record holds how the House and the Senate voted on them. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. | Became law | Public Law 119-21House 218–214 · Senate 50–50 |
| H.R. 5371Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 | Became law | Public Law 119-37House 222–209 · Senate 60–40 |
| H.R. 7148Consolidated Appropriations Act, 2026 | Became law | Public Law 119-75House 217–214 · Senate 71–29 |
| H.R. 946ORPHAN Cures Act | Introduced | No recorded vote in our record |
| H.R. 950Saving Seniors Money on Prescriptions Act | Introduced | No recorded vote in our record |
| H.R. 1262Mikaela Naylon Give Kids a Chance Act | Passed the House | No recorded vote in our record |
| H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | Introduced | No recorded vote in our record |
| H.R. 1672Maintaining Investments in New Innovation Act | Introduced | No recorded vote in our record |
| H.R. 2214DRUG Act | Introduced | No recorded vote in our record |
| H.R. 2425Kairo Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 3037Access to Breast Cancer Diagnosis Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 3152Patent Eligibility Restoration Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 3160PREVAIL Act | Introduced | No recorded vote in our record |
| H.R. 3269ETHIC Act | Introduced | No recorded vote in our record |
| H.R. 5256340B ACCESS Act | Introduced | No recorded vote in our record |
| H.R. 5391Bipartisan Bulletproof Vest Partnership Program Expansion Act | Introduced | No recorded vote in our record |
| H.R. 8800National Defense Authorization Act for Fiscal Year 2027 | Passed the House | No recorded vote in our record |
| H.R. 9102BINSA Act | Introduced | No recorded vote in our record |
| H.R. 9504Tax Exempt Hospital Transparency Act | Introduced | No recorded vote in our record |
| H.R. 9599SECURE 340B Act | Introduced | No recorded vote in our record |
| S. 43Skinny Labels, Big Savings Act | Introduced | No recorded vote in our record |
| S. 832EPIC Act of 2025 | Introduced | No recorded vote in our record |
| S. 864HELP Copays Act | Introduced | No recorded vote in our record |
| S. 932Give Kids a Chance Act of 2025 | Introduced | No recorded vote in our record |
| S. 1041Affordable Prescriptions for Patients Act | Passed the Senate | No recorded vote in our record |
| S. 1095Stop STALLING Act | Reported by committee | No recorded vote in our record |
| S. 1096Preserve Access to Affordable Generics and Biosimilars Act | Reported by committee | No recorded vote in our record |
| S. 1097Interagency Patent Coordination and Improvement Act of 2025 | Reported by committee | No recorded vote in our record |
| S. 1500Access to Breast Cancer Diagnosis Act of 2025 | Introduced | No recorded vote in our record |
| S. 1546Patent Eligibility Restoration Act of 2025 | Introduced | No recorded vote in our record |
| S. 1682Alex Gate Safety Act of 2025 | Introduced | No recorded vote in our record |
| S. 2276ETHIC Act | Introduced | No recorded vote in our record |
| S. 2764STUDENT Act | Introduced | No recorded vote in our record |
| S. 3788CLEAR LABELS Act | Reported by committee | No recorded vote in our record |
| S. 4784National Defense Authorization Act for Fiscal Year 2027 | Reported by committee | No recorded vote in our record |
Issues named: Budget/Appropriations (1), Copyright/Patent/Trademark (1), Health Issues (1), Labor Issues/Antitrust/Workplace (1), Medicare/Medicaid (1), Taxation/Internal Revenue Code (1), Trade (domestic/foreign) (1).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| NOVARTISBudget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
| Member | Paid to, as reported | Amount | Date | Report |
|---|---|---|---|---|
| Donald G. Davis DDemocrat | DON DAVIS FOR NCFrom NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE | $5,000 | The report on LDA.gov | |
| Sarah McBride DDemocrat | MCBRIDE FOR DELAWARE INCFrom NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE | $1,000 | The report on LDA.gov | |
| Donald G. Davis DDemocrat | DON DAVIS FOR NCFrom NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE | $4,000 | The report on LDA.gov | |
| Brian K. Fitzpatrick RRepublican | BRIAN FITZPATRICK FOR ALL OF USFrom NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE | $1,000 | The report on LDA.gov | |
| Donald G. Davis DDemocrat | DON DAVIS FOR NCFrom NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE | $1,000 | The report on LDA.gov |
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.